ACAD
34.08
-1.78
-4.9635%
AEMD
3.38
-0.02
-0.59%
APRI
2.16
-0.05
-2.26%
ARNA
1.445
+0.005
+0.347%
ATEC
2.4
0.00
+0.02%
CNAT
5.12
+0.1
+1.99%
CRXM
0.17
-0.02
-10.3684%
CYTX
1.605
-0.005
-0.311%
DXCM
84.79
-0.4
-0.47%
GNMK
12.78
+0.22
+1.75%
HALO
12.651
-1.639
-11.470%
ILMN
173.2
+0.54
+0.31%
INNV
0.108
+0.003
+2.370%
INO
6.53
-0.04
-0.61%
ISCO
1.69
-0.11
-6.11%
ISIS
57.56
0.00
0.00%
LGND
106.06
-0.05
-0.05%
LPTN
2.93
0.00
0.00%
MBVX
2.17
-0.03
-1.36%
MEIP
1.6
0.00
0.00%
MNOV
5.97
+0.07
+1.19%
MRTX
5.15
0.00
0.00%
MSTX
0.12
-0.001
-0.4139%
NBIX
41.25
-1.68
-3.91%
NUVA
75.24
-0.08
-0.11%
ONCS
1.305
-0.035
-2.612%
ONVO
3.128
+0.048
+1.5422%
OREX
3.893
-0.097
-2.4336%
OTIC
12.1
-0.15
-1.22%
QDEL
22.53
+0.08
+0.36%
RCPT
231.96
0.00
0.00%
RGLS
1.55
-0.1
-6.06%
RMD
71.645
-0.835
-1.152%
SPHS
2.83
+0.03
+1.07%
SRNE
3.975
-0.075
-1.852%
TROV
1.15
+0.1
+9.52%
VICL
2.294
-0.017
-0.7143%
VOLC
18
0.00
0.00%
ZGNX
11
-0.25
-2.22%
ACAD
34.08
-1.78
-4.9635%
AEMD
3.38
-0.02
-0.59%
APRI
2.16
-0.05
-2.26%
ARNA
1.445
+0.005
+0.347%
ATEC
2.4
0.00
+0.02%
CNAT
5.12
+0.1
+1.99%
CRXM
0.17
-0.02
-10.3684%
CYTX
1.605
-0.005
-0.311%
DXCM
84.79
-0.4
-0.47%
GNMK
12.78
+0.22
+1.75%
HALO
12.651
-1.639
-11.470%
ILMN
173.2
+0.54
+0.31%
INNV
0.108
+0.003
+2.370%
INO
6.53
-0.04
-0.61%
ISCO
1.69
-0.11
-6.11%
ISIS
57.56
0.00
0.00%
LGND
106.06
-0.05
-0.05%
LPTN
2.93
0.00
0.00%
MBVX
2.17
-0.03
-1.36%
MEIP
1.6
0.00
0.00%
MNOV
5.97
+0.07
+1.19%
MRTX
5.15
0.00
0.00%
MSTX
0.12
-0.001
-0.4139%
NBIX
41.25
-1.68
-3.91%
NUVA
75.24
-0.08
-0.11%
ONCS
1.305
-0.035
-2.612%
ONVO
3.128
+0.048
+1.5422%
OREX
3.893
-0.097
-2.4336%
OTIC
12.1
-0.15
-1.22%
QDEL
22.53
+0.08
+0.36%
RCPT
231.96
0.00
0.00%
RGLS
1.55
-0.1
-6.06%
RMD
71.645
-0.835
-1.152%
SPHS
2.83
+0.03
+1.07%
SRNE
3.975
-0.075
-1.852%
TROV
1.15
+0.1
+9.52%
VICL
2.294
-0.017
-0.7143%
VOLC
18
0.00
0.00%
ZGNX
11
-0.25
-2.22%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …